(S,R,S)-AHPC (MDK7526)

(S,R,S)-AHPC (MDK7526) is an inhibitor of E3 Ligase and Androgen Receptor used in studies of Protein Degradation / Proteasome and Hormone Signaling. In practice, this places the compound in experiments that measure ubiquitin-dependent turnover, proteostasis, and targeted protein degradation and ligand-dependent transcriptional programs and endocrine regulation in cancer, endocrinology, and protein homeostasis models.

By inhibiting E3 Ligase and Androgen Receptor, (S,R,S)-AHPC (MDK7526) can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation and ligand-dependent transcriptional programs and endocrine regulation. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cancer, endocrinology, and protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving E3 Ligase and Androgen Receptor
• Pathway perturbation studies connected to Protein Degradation / Proteasome and Hormone Signaling
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, (S,R,S)-AHPC (MDK7526) is appropriate when a defined chemical perturbant is needed to connect E3 Ligase and Androgen Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, endocrinology, and protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.